The kiss of death: promises and failures of death receptors and ligands in cancer therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/2402169.pdf
Reference154 articles.
1. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME . Apoptosis signaling by death receptors Eur J Biochem 1998 254: 439–459
2. Drappa J, Vaishnaw AK, Sullivan KE, Chu JL, Elkon KB . Fas gene mutations in the Canale–Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity N Engl J Med 1996 335: 1643–1649
3. Martin DA, Zheng L, Siegel RM, Huang B, Fisher GH, Wang J, Jackson CE, Puck JM, Dale J, Straus SE, Peter ME, Krammer PH, Fesik S, Lenardo MJ . Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia Proc Natl Acad Sci USA 1999 96: 4552–4557
4. Jackson CE, Puck JM . Autoimmune lymphoproliferative syndrome, a disorder of apoptosis Curr Opin Pediatr 1999 11: 521–527
5. Vaishnaw AK, Orlinick JR, Chu JL, Krammer PH, Chao MV, Elkon KB . The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations J Clin Invest 1999 103: 355–363
Cited by 165 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer;Experimental & Molecular Medicine;2024-01-10
2. Nimesulide, a COX-2 inhibitor, sensitizes pancreatic cancer cells to TRAIL-induced apoptosis by promoting DR5 clustering †;Cancer Biology & Therapy;2023-02-12
3. CCN1 suppresses cell proliferation of esophageal squamous cell carcinoma through amyloid precursor protein without DR6 participation;Cellular Signalling;2022-08
4. RETRACTED ARTICLE: Overexpression of CCN1 in esophageal squamous cell carcinoma attenuates cell proliferation through amyloid precursor protein without DR6 involvement;Human Cell;2022-05-31
5. Exploring the Mitochondrial Apoptotic Cell Death Landscape and Associated Components Serving as Molecular Targets, Primarily for Synthetic and Natural Drugs Targeting Oncology Therapeutics;Current Molecular Pharmacology;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3